These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6214145)

  • 1. [Effect of oxalysine on plasma fibrinogen content in tumor-bearing mice (author's transl)].
    Yue XF; Wu FG; Xu B
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):124-8. PubMed ID: 6214145
    [No Abstract]   [Full Text] [Related]  

  • 2. [The anticancer and pharmacologic study of oxalysine (author's transl)].
    Yue XF; Wu FG; Xu B
    Yao Xue Xue Bao; 1980 Jul; 15(7):391-5. PubMed ID: 6775491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of oxalysine (I-677) on the incorporation of lysine and its subcellular distribution].
    Yue XF; Wu SY; Wu FG; Gui JZ; Xu B
    Zhongguo Yao Li Xue Bao; 1983 Mar; 4(1):54-7. PubMed ID: 6223501
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunopotentiating effects of oxalysine].
    Li XY; Tong LM; Jin YF; Cao CY; Liang HZ; Wang JF; Zhu PP; Wang JY
    Zhongguo Yao Li Xue Bao; 1987 Mar; 8(2):173-7. PubMed ID: 2959008
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of oxalysine on pulmonary metastases of Lewis lung carcinoma in mice].
    Yue XF; Wu FG; Xu B
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):198-200. PubMed ID: 2943127
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of some antineoplastic drugs on inhibiting thrombin catalizing fibrinogen clotting in vitro.
    Lu D; Cao J; Huang Y; Gong L; Chen X; Chen E; Xu B
    Chin Med J (Engl); 1999 Nov; 112(11):1052-3. PubMed ID: 11721472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor and immunological activities of oxalysine].
    Wang X; Xu B
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):115-7. PubMed ID: 10743074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of L-4-oxalysine on ultrastructures of liver cells in mice.
    Dai ZQ; Yu YG; Zhu PP; Yuan XJ; Xu JY; Li XY
    Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):336-40. PubMed ID: 1807083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bleomycin A derivative, 99mTc-BLAIDA: synthesis and distribution in tumor-bearing mice (author's transl)].
    Hu YL; Xie YY; Tao ZQ; Chen ZJ; Zhang JS; Ding GS
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):120-4. PubMed ID: 6214144
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nucleolus segregation of tumor cells induced by actinomycin K and lycobetaine (author's transl)].
    Wang ZW; Shu RS; Xu B
    Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):48-51. PubMed ID: 6178253
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of L-4-oxalysine on carbon tetrachloride-induced changes in drug-metabolizing enzyme activity of mouse liver.
    Zeng YL; Ten Wolde-Kraamwinkel HC; Baars AJ; Breimer DD
    Xenobiotica; 1982 Jul; 12(7):463-6. PubMed ID: 6815904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulatory action of L-4-oxalysine counteracts immunosuppression induced by alpha-fetoprotein.
    Wang XW; Xu B
    Eur J Pharmacol; 1998 Jun; 351(1):105-11. PubMed ID: 9698211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Distribution of I-131-labeled fibrinogen in the organs and tissues of mice with transplanted tumors].
    Gasperovich NV
    Med Radiol (Mosk); 1966 Dec; 11(12):58-9. PubMed ID: 6004363
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on antitumor antibiotic 1588. III. Experimental treatment of animal tumor (author's transl)].
    Yang GZ; Xu ZM
    Yao Xue Xue Bao; 1981 Nov; 16(11):811-4. PubMed ID: 6177193
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoregulatory activities of L-4-oxalysine: an in vitro study.
    Wang XW; Xu B
    Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):437-42. PubMed ID: 9413826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification of radiation effect by showdomycin on hair roots of the mouse (author's transl)].
    Egawa J; Ishioka K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Oct; 34(10):763-8. PubMed ID: 4533784
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action and molecular targets of anti cancer agents from microbial products].
    Ishizuka M
    Jpn J Antibiot; 1999 Feb; 52(2):174-5. PubMed ID: 10221183
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of glutamate transporter inhibitors on the antitumor activity of doxorubicin.
    Sadzuka Y; Yamashita Y; Sonobe T
    Clin Cancer Res; 2002 Dec; 8(12):3943-7. PubMed ID: 12473610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity and sister chromatid exchanges induced in vitro by six anticancer drugs developed in the People's Republic of China.
    Huang CC; Han CS; Yue XF; Shen CM; Wang SW; Wu FG; Xu B
    J Natl Cancer Inst; 1983 Oct; 71(4):841-7. PubMed ID: 6413744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.